Fariba F. Ghodsian, Ph.D., MBA
Chief Investment Officer

Dr. Fariba Ghodsian is Chief Investment Officer and Managing Member of the General Partner.

Dr. Ghodsian received her M.B.A. from the University of California at Los Angeles in 1991, and completed her postdoctoral fellowship in protein modeling at Harvard Medical School in 1988. She received her Ph.D. in Biomedical Engineering from Oxford University in England in 1987, M.S. in Chemical Engineering from Massachusetts Institute of Technology in 1985, and B.S. in Chemical Engineering from Technion, Israel Institute of Technology in 1983.

Prior to joining the firm in 2002, Dr. Ghodsian was the Managing Director of Healthcare Research at Roth Capital Partners in Los Angeles. Before this, she was a senior biotechnology analyst at Lehman Brothers, Hancock Institutional, and Wedbush Morgan Securities, as well as Director of Business Development at Medclone and a research scientist at Allergan Pharmaceuticals.